MyAverix Finance
F · Healthcare
SYNACT PHARMA AB (8F8)
Biotechnology
SYNACT PHARMA AB (8F8) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8F8
SYNACT PHARMA AB (8F8) — FAQ
What is 8F8's P/E ratio?
The price-to-earnings (P/E) ratio for SYNACT PHARMA AB (8F8) is 25.00 (data as of 2026-05-23).
Does SYNACT PHARMA AB pay a dividend?
Dividend yield is not available in the current snapshot for SYNACT PHARMA AB (8F8). Check the MyAverix Finance app for the latest dividend data.
What sector is SYNACT PHARMA AB in?
SYNACT PHARMA AB (8F8) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 8F8 listed on?
8F8 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.